Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors
Related Posts
Dunn DP, Dani G, Sharma A, Ioannou GN, Taddei TH, Chang ST, Onyiuke IY, Planeta BM, Huang GD, Weiss NS, Morgan TR, Dominitz JA, Abou-Alfa[...]
Chang L, Staller K, Houghton LA, Yerneni N, Higgins S, Chen W, Wu J, Ford AC, Feuerstadt P, Brenner DM. Effect of Age and Age-Defined[...]
IsHak WW, Hamilton MA, Diniz MA, Mirocha J, Chernoff R, Hedrick R, Aronow H, Darwish T, Messineo G, Pasini M, Olanisa L, Tetrault E, Arun[...]